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days after the onset of illness and may remain in positive for
3-6 months.  A negative initial  test does not exclude the
diagnosis in an appropriate clinical setting.  Dengue IgG
antibody becomes positive in 7-10 days and remains so for
life. In secondary infections levels of IgG antibody may rise
rapidly in the acute phase, whereas IgM antibody levels
may remain low or absent.19
There is no specific treatment for this self limiting
disease. Supportive care should be provided. Patients
should be well hydrated and those who cannot maintain an
adequate intake orally must be given intravenous fluids.
Platelets and fresh frozen plasma are only indicated in the
event of serious bleeding. Platelet infusions are usually only
required when the platelet count falls below 20,000/Cmm.
Aspirin , NSAIDS and antibiotics should be avoided. 
A high index of suspicion, clinical vigilance, daily
monitoring for haematocrit rise, falling  platelet count ,
DIC, coagulopathy and institution  of prompt supportive
care are life saving. In centres experienced in handling these
cases mortality has been reduced to 0.2% with the prompt
institution of appropriate supportive measures.6 Prevention
lies in vector control by  all possible means, primarily  by
measures which eliminate  breeding areas for Aedes
aegypti. Dengue patients should  be protected from further
mosquito bites to contain spread of infection. Protective
vaccine is elusive at present, but live attenuated, tetravalent
dengue vaccines have been shown to be immunogenic  and
safe and are undergoing further trials.20
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Developmental Dysplasia of Hip - Where do we stand?
Masood Umer, Haq Nawaz
Department of Surgery, Aga University, Stadium Road, Karachi.
Developmental Dysplasia of the Hip (DDH) is a
clinical condition requiring specialized and dedicated
people for its treatment. The treating surgeon should
have a sound knowledge of the factors responsible for
normal growth, patho-anatomy, obstacles to reduction,
natural history of the disease and reasons for failure of
treatment before daring into treating DDH. The treatment
becomes more complex and challenging with increasing
age of the child.1
As the day and age of sub- and super-specialization
is dawning, the results of its treatment, especially in the
older children (walking age group) in the developed world
have improved considerably.2 Unfortunately, we, in
Pakistan do not have many fellowship trained dedicated
paediatric orthopaedic surgeons; hence most patients end up
being treated by 'general orthopedic surgeons' who have a
variable experience in treating this condition. Most of them
have learned to treat DDH by default and hardly any by
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their choice. Personally, I have witnessed even some of the
senior graduating residents being unable to put on a pavlik
harness or a Von Rosen splint on to a neonate for dislocated
hip. Proper use of these devices within the first few months
of life and meticulous monitoring ensures excellent
results3,4 with success rates as high as 95% in expert hands.
There is thus an imminent need for a focus on this aspect in
the regular orthopaedic postgraduate curriculum. The recent
efforts by Pakistan Orthopaedic Association to create sub-
specialty forums is a step in the right direction. A workshop
on applying the DDH splints was also held in this
connection by the paediatric orthopaedics forum last year.
Such brilliant efforts need to be continued on a regular
basis. As realization about this deficiency in residency
training grows, more and more students will be interested to
attend such workshops.   
Parents of children with DDH are usually unaware of
the training level and expertise of a particular surgeon when
they approach an orthopaedic surgeon for the treatment of
their child. The treatment results are thus very variable and
most are never reported. Patients ending up with
complications are labeled under 'God's will' and the primary
surgeon occasionally has no idea of what went wrong
during the procedure; the challenge of offering a revision
procedure can only be undertaken once the pitfalls of the
primary surgery are identified. A similar example is to order
x-ray for evaluation of newborn with suspected DDH which
is not indicated in this age-group.5 Parents of children with
DDH should therefore be educated to approach a
specialized orthopaedic surgeon for the treatment of their
child's condition or one who has considerable experience in
treating DDH. Parental counseling is also invaluable during
the entire treatment process and can play a key role in
successful treatment especially with the harness.
Based on personal clinical experience, it is common
knowledge that DDH has a lower incidence rate than other
common conditions like septic hip arthritis or acute
proximal femoral osteomyelitis. No formal studies reporting
the incidence of DDH in Pakistan have been reported so far.
In the west, it is around 5 in 1000 hips and risk factors
include first born, female sex, positive family history,
breech presentation and oligohydramnios.6 Other associated
factors include ethnic background (e.g. Native American),
torticollis and lower limb deformity.5 Epidemiological
studies are desperately needed in our part of the world to
isolate families and ethnic groups who are suffering from
this problem. Preventive strategies can then be targeted
towards them. A common observation is the absence of
DDH in communities where mothers carry neonates on their
backs with hips abducted apart. One can hypothesize that
carrying and maintaining a neonate in a 'pangoora' by the
bedside with both legs tightly adducted may have an
opposite effect. This is routine in some segments of our
society and we need to study the rates of DDH in these
families.    
Routine screening of the newborn should include
both the Ortolani test and the Barlow maneuver. All
orthopaedic and especially paediatric medicine residents
need to master the techniques of these two tests. Paediatric
medicine residents are the first ones examining all
newborns. It is their high index of suspicion that will raise
alarms and calls for orthopaedic consultation. An
opportunity of diagnosis missed at birth is usually paid very
heavily by the child and his/her parents in later years as
delayed treatment becomes more complicated and
challenging. The use of ultrasound for routine screening has
huge financial implications and should be restricted only to
high risk categories mentioned above.7 It is one of the best
imaging modality to show real-time pictures of the hip joint
in a neonate.8 Dedicated paediatric orthopaedic surgeons
need to master its technique and have a machine in their
clinic to facilitate regular monitoring.      
Surgical treatment of DDH is reserved for children
in the walking age group.4 The goals are to create normal
anatomy of the proximal femur and acetabulum and
maintain that anatomy to allow normal development of hip
function. With experience and greater understanding of the
outcomes, surgical recommendations have also changed.
Pre-operative traction has been replaced by femoral
shortening.9 A simultaneous open reduction, femoral
shortening, de-rotation, and acetabuloplasty, all together
known as the triple procedure, are now the current
recommendations in an older child.10,11 This is a
complicated surgery, and the outcome has a direct
correlation with experience. The need for early referral to a
specialized care centre is again emphasized. 
The value of objectively evaluating one's results is
tremendous. Several universally accepted evaluation
criteria such as the Severin's scoring system12 and the Iowa
hip score13 for evaluating hip function are available. They
serve as the basis for objective analysis and presentation of
results. Young surgeons entering into this specialized field
are encouraged to maximize the use of these internationally
accepted systems in their routine pre- and post-op
evaluations. Hardly a couple of studies documenting the
results of treatment of DDH could be found in the local
literature.14 This is despite the fact that DDH is being
treated in every major public and private teaching hospital
of the country. The objective of writing a manuscript can
only be achieved once proper documentation and objective
evaluation are incorporated from the very beginning and
become part of routine practice. Production of quality
scientific papers on their surgical work is probably the best
reflection of any good residency program in the country. 
In general, paediatricians and family practitioners
should refer a child with DDH for specialist care as early as
possible. The outcome of treatment during the first six
months of life is much better and predictable than in late-
diagnosed DDH. Dedicated surgeons sub-specializing in
paediatric orthopaedics is the need of the day. 
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Dengue fever outbreak in Karachi 2006 - A study of profile and outcome of
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Abstract
Objective: To evaluate children with serologically confirmed Dengue fever in order to identify common clinical
features, progress of disease, grades of severity and outcome of cases during the outbreak in 2006.
Methods: A cross-sectional, descriptive study was conducted on serologically positive children with Dengue
fever (DF) admitted in Civil Hospital Karachi and Liaquat National Hospital between October and November
2006. Various clinical features and laboratory parameters were analyzed for frequencies. Data was also
evaluated to identify the common clinical types and grades of infection as classified by WHO.
Results:A total of 35 children were evaluated in the study. Mean age of children was 8.3 ± 3.5 years and majority
was male (54%). Sixty five percent were under 10 ± 3.5 years of age. Frequent clinical features included fever
(97%), vomiting (68%), abdominal pain (68%) and rashes (65%). Gastrointestinal bleeding (61%) and epistaxis
(26%) were commonest haemorrhagic manifestations. Thrombocytopenia (86%), anaemia (57%) and
Leucopenia (43%) were common laboratory findings. Leukocyte count improved in 2 to 7 days and Platelet count
in 2 to 8 days. Dengue haemorrhagic fever (DHF) was seen in 22 children (62%). Majority had Grade-II severity.
Mortality was 1 (3%) out of 35 patients.
Conclusion: 2006 outbreak of Dengue infection in Karachi showed slight difference in clinical features and
course of disease compared to epidemics in other regions, thereby, indicating the need for continuous sero-
epidemeological surveillance (JPMA 58:4;2008).
Introduction
Dengue is an important mosquito borne viral
infection. It occurred sporadically till the 19th century.
Recent years have seen epidemics of this arthropod borne
viral disease and presently it is endemic in 112 countries
around the world.1,2 Dengue virus is an RNA virus of
flaviridae family, with four serotypes, transmitted by the
bite of Aedes aegypti mosquito. It manifests in three ways,
a mild atypical form, classic Dengue and Dengue
haemorrhagic fever3 which may evolve into Dengue shock
syndrome. Mortality can occur in Dengue shock syndrome
unless prompt and adequate management with fluid
replacement is provided.
